PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
19-Jan-2023 HUTCHMED Announces Agreement with NHSA for Inclusion of ORPATHYS® in the National Reimbursement Drug List in China HUTCHMED
19-Jan-2023 PIONEERING ORAL TREATMENT GREENLIT FOR MYELOMA PATIENTS Myeloma UK
19-Jan-2023 Vitruvia Medical AG: Cooperation with TRES MEDICO, Malaysia Vitruvia Medical AG
19-Jan-2023 ​​​​​​​PAION ANNOUNCES SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY ITS LICENSEE CRISTÁLIA IN BRASIL PAION AG
19-Jan-2023 Servier and Taiho Oncology Present Overall Survival Data for Trifluridine/Tipiracil (LONSURF®) In Combination With Bevacizumab in Patients With Refractory Metastatic Colorectal Cancer at 2023 ASCO Gastrointestinal Cancers Symposium Servier and Taiho Oncology
19-Jan-2023 DeuterOncology closes €5.65M Series A financing round  Andrew Lloyd Associates
19-Jan-2023 Zur Rose Group: Revenue target 2022 achieved, EBITDA better than expected Zur Rose Group AG
19-Jan-2023 Biotest AG: Biotest receives 'Innovation Champion of Sustainability' award Biotest AG
18-Jan-2023 Biophytis: Judgment of the Paris Court of Appeal of 17 January 2023 in the case between Biophytis and Negma Group Ltd Biophytis
18-Jan-2023 Strength in Sustainability: Vetter Wins Gold in EcoVadis Ranking B3C newswire
18-Jan-2023 ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production ProBioGen
18-Jan-2023 Clinical trial gives terminal cancer patient new lease of life The Christie
18-Jan-2023 AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease AC Immune
18-Jan-2023 PRIMARY TUMOR OR METASTASIS? Karl Landsteiner University of Health Sciences
18-Jan-2023 Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults Moderna
18-Jan-2023 Hataali 2.0 creates a single interoperable platform for the entire advanced therapy ecosystem Hataali
18-Jan-2023 Spectral MD (SMD.L*): Interim results from DFU trial shows improvement in DeepView diagnostic accuracy Spectral MD
18-Jan-2023 Positive Interim Results from DFU Clinical Study & Burn Clinical Study Update Spectral MD Holdings, Ltd.
18-Jan-2023 ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production B3C newswire
17-Jan-2023 Greenphire Appoints Owen Newman as Chief Financial Officer to Accelerate Company Growth Greenphire